维普期刊资源整合服务平台（V6.5）

111篇 您的检索式：作者名="Teerlink T"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Asymmetrical dimethylarginine(ADMA) in critically ill patients:high plasma ADMA concentration is an independent risk factor of ICU mortality显示文摘	Nijveldt RJ Teerlink T Van Der Hoven B	2003	Clin Nutr2003，22，11：	1
2	Asymmetrical dimethylarginine (ADMA) in critically ill patients:high plasma ADMA concentration is an independent risk factor of ICU mortality显示文摘	Nijveldt RJ Teerlink T van der Hoven B	2003	Clin Nutr2003，22，1：	1
3	Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes显示文摘	Tarnow L Hovind P Teerlink T	2004	Diabetes Care2004，27，3：	1
4	Ultrastructural localization of a peroxisomal protein in rat liver using the specific antibody against the non-specific lipid transfer protein(sterol carrier protein 2)显示文摘	Van der Krift TP Leunissen J Teerlink T	1985	Biochim Biophys Acta1985，812，：	1
5	Raised plasma levels of asymmetric dimethylarginine are associated with cardiovascular events,disease activity,and organ damage in patients with systemic lupus erythematosus显示文摘	Bultink IE Teerlink T Heijst JA	2005	Ann Rheum Dis2005，64，9：	1
6	Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes显示文摘	Tanmw L Hovind P Teerlink T	2004	Diabetes Care2004，27，：	1
7	显示文摘	Nijveldt R I Teerlink T Van der Hoven B	2003	Clin Nutr2003，22，：	1
8	The clinical significance of asymmetric dimethylarginine 显示文摘	Siroen M P Teerlink T Nijveldtr J	2006	Annu Rev Nutr2006，26，：	1
9	The clinical significance of asymmetric dimethylarginine显示文摘	SIROEN M P TEERLINK T NIJVELDT R J	2006	Annu Rev Nutr2006，26，：	1
10	Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification 显示文摘	Schindhelm RK van der Zwan LP Teerlink T	2009	Clin Chem2009，55，8：	1
11	Arginine defici-ency in bile duct-ligated rats after surgery: the role of plasma arginase and gutendotoxin restriction显示文摘	Teerlink T Visser JJ	1997	Gastroenterology1997，113，4：	1
12	Determination of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in biological samples by HPLC显示文摘	TEERLINK T	2005	Methods Mol Med2005，108，：	1
13	Angiotensin Ⅱ and NADPH oxidase increase ADMA in vascular smooth muscle cells 显示文摘	Luo Z Teerlink T Griendting K	2010	Hypertension2010，56，3：	1
14	S-adenosylhomocysteine and the ratio of S-adenosylmethionine to S-adenosylhomocysteine are not related to folate,cobalamin and vitamin B6 concentrations显示文摘	Becker A Smulders YM Teerlink T	2003	Eur J Clin Invest2003，33，1：	1
15	Asymmetric dimethylarginine (ADMA) as a risk nmrker for stroke and TIA in a Swedish population 显示文摘	Wanby P Teerlink T Brudin L	2006	Atherosclerosis2006，185，3：	1
16	Asymmetric dimethylarginine(ADMA)as a risk marker for stroke and TIA in a Swedish population显示文摘	Wanby P Teerlink T Brudin L	2006	Atherosclerosis2006，185，2：	1
17	Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification? 显示文摘	Schindhelm RK van der Zwan LP Teerlink T	2009	Clin Chem2009，55，8：	1
18	Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish popula- tion 显示文摘	Wanby P Teerlink T Brudin L	2006	Atherosclerosis2006，185，2：	1
19	ADMA metabolism and clearance显示文摘	Teerlink T	2005	Vase Med2005，10，1：	1
20	Increased levels of N (epsilon)-(carboxymethyl) lysine and N ( epsilon ) -( carboxyethyl) lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction 显示文摘	Lieuw-A-Fa ML van Hinsbergh VW Teerlink T	2004	Nephrol Dial Transplant2004，19，3：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示